MedTrace Logo

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

NCT01112956 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2011-03-23

No results posted yet for this study

Summary

The purposes of this study are:

* To determine the accuracy of commercially available serologic assays in diagnosing patients with herpes simplex virus type 2 (HSV-2);
* To assess the sensitivity and specificity of the commerical assays using HSV-2 western blot as the "gold standard" in a diverse patient population;
* To develop testing strategies and recommendations for screening asymptomatic populations for HSV-2.

Conditions

  • Genital Herpes

Sponsors & Collaborators

Principal Investigators

  • Donna Felsenstein, MD · Massachusetts General Hospital

Eligibility

Min Age
16 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2010-12-31
Completion
2011-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01112956 on ClinicalTrials.gov